← All trials
NCT04717830
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Jan 31, 2022
- First posted
- Jan 22, 2021
- Last posted
- Feb 18, 2021
- Enrollment
- 25
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of RussiaLead sponsor
- Research Institute of Influenza, RussiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.